Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women

Menopause

Volumn 11, Issue 1, 2004, Pages 49-56

  Dessole, Salvatore ^a,d   Rubattu, Giovanni ^a   Ambrosini, Guido ^b   Gallo, Omar ^a   Capobianco, Giampiero ^a   Cherchi, Pier Luigi ^a   Marci, Roberta ^c   Cosmi, Erich ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d Department of Gynecology ^*  (Italy)

Author keywords

Low dose estrogen; Postmenopausal women; Recurrent urinary tract infections; Urinary incontinence; Urogenital atrophy; Vaginal estriol

Indexed keywords

ESTRIOL;

ABDOMINAL PRESSURE; ADULT; AGED; AGING; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; ESTROGEN THERAPY; EVALUATION; FEMALE; GYNECOLOGIC DISEASE; HORMONAL THERAPY; HUMAN; LOW DRUG DOSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PATIENT SATISFACTION; POSTMENOPAUSE; PRESSURE MEASUREMENT; PROSPECTIVE STUDY; RANDOMIZATION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT CONTRAINDICATION; URETHRA DISEASE; URETHRA PRESSURE; URETHROCYSTOMETRY; URINARY TRACT INFECTION; URINE CULTURE; UROGENITAL TRACT DISEASE; ATROPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DYSPAREUNIA; INTRAVAGINAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; STRESS INCONTINENCE; UROGENITAL SYSTEM; VAGINA; VAGINA DISEASE;

ADMINISTRATION, INTRAVAGINAL; AGED; AGING; ATROPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSPAREUNIA; ESTRIOL; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; RECURRENCE; URINARY INCONTINENCE, STRESS; URINARY TRACT INFECTIONS; UROGENITAL SYSTEM; VAGINA; VAGINAL DISEASES;

EID: 1942504510     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000077620.13164.62     Document Type: Article

References (48)

1. Lovatsis D, Drutz HP. The role of estrogen in female urinary incontinence and urogenital aging: a review. Ostomy Wound Manage 1998;44:48-53.
2. Greendale GA, Judd HL. The menopause: health implications and clinical management. J Am Geriatr Soc 1993;41:426-436.
3. Cardozo L, Bachmann G, McClish D, Fonda D, Birgenson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the hormones and urogenital therapy committee. Obstet Gynecol 1998;92:722-727.
4. Barlow DH, Samsioe G, van Geelen JH. A study of European women's experience of the problems of urogenital ageing and its management. Maturitas 1997;27:239-247.
5. Samsioe G. Urogenital aging. A hidden problem. Am J Obstet Gynecol 1998;178:S245-S249.
6. Iosif CS, Batra S, Ek A, Astedt B. Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 1981;141:817-820.
7. Smith P. Estrogens and the urogenital tract. Acta Obstet Gynecol Scand 1993;157(Suppl):1-25.
8. Versi E, Brincat M, Cardozo LD. Correlation of urethral physiology and skin collagen in postmenopausal women. Br J Obstet Gynecol 1988;95:147-152.
9. Falconer C, Ekman-Ordeberg G, Ulmsten U, Westergren-Thorsson G, Barchan K, Malmstrom A. Changes in paraurethral connective tissue at menopause are counteracted by estrogen. Maturitas 1996; 24:197-204.
10. Samsioe G, Jansson I, Mellstrom D, Svanborg A. Occurrence, nature and treatment of urinary incontinence in a 70-year-old female population. Maturitas 1985;7:335-342.
11. Nilsson K, Heimer G. Low-dose estradiol in the treatment of urogenital oestrogen deficiency: a pharmacokinetic and pharmacodynamic study. Maturitas 1992;15:121-127.
12. Smith P, Heimer G, Lindskog M, Ulmsten U. Estradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitas 1993;16:145-154.
13. Fantl JA, Cardozo L, McClish DK. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the hormones and urogenital therapy committee. Obstet Gynecol 1994;83:12-18.
14. Esposito G. Estriol: a weak estrogen or a different hormone? Gynecol Endocrinol 1991;5:131-153.
15. Gerbaldo D, Ferraiolo A, Croce S, Truini M, Capitanio GL. Endometrial morphology after 12 months of vaginal oestriol therapy in postmenopausal women. Maturitas 1991;13:269-274.
16. Heimer GM, Englund DE. Effects of vaginally-administered oestriol on postmenopausal urogenital disorders: a cytohormonal study. Maturitas 1992;14:171-179.
17. Iosif CS. Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women. Arch Gynecol Obstet 1992;251:115-120.
18. Foidart JM, Vervliet J, Buytaert P. Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints. Maturitas 1991;13:99-107.
19. Van der Linden MC, Gerretsen G, Brandhorst MS, Ooms EC, Kremer CM, Doesburg WH. The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito-urinary symptoms. Eur J Obstet Gynecol Reprod Biol 1993;51:29-33.
20. Henriksson L, Stjernquist M, Boquist L, Alander U, Selinus I. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 1994;171:624-632.
21. Bottiglione F, Volpe A, Esposito G, Aloysio DD. Transvaginal estriol administration in postmenopausal women: a double blind comparative study of two different doses. Maturitas 1995;22:227-232.
22. Barentsen R, van de Weijer PH, Schram JH. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 1997;71: 73-80.
23. Dugal R, Hesla K, Sordal T, Aase KH, Lilleeidet O, Wickstrom E. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Acta Obstet Gynecol Scand 2000;79:293-297.
24. Kanne B, Jenny J. Local administration of low-dose estriol and vital Lactobacillus acidophilus in postmenopause [in German]. Gynakol Rundsch 1991;31:7-13.
25. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329:753-756.
26. Blum M. Benefits of vaginal estriol cream combined with clonidine HCL for menopausal syndrome treatment. Clin Exp Obstet Gynecol 1985;12:1-2.
27. Melis GB, Cagnacci A, Bruni V, et al. Salmon calcitonin plus intra-vaginal estriol: an effective treatment for the menopause. Maturitas 1996;24:83-90.
28. Beisland HO, Fossberg E, Moer A, Sander S. Urethral sphincteric insufficiency in postmenopausal females: treatment with phenylpropanolamine and estriol separately and in combination. A urodynamic and clinical evaluation. Urol Int 1984;39:211-216.
29. Ahlstrom K, Sandahl B, Sjoberg B, Ulmsten U, Stormby N, Lindskog M. Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence. Gynecol Obstet Invest 1990;30:37-43.
30. Sacco F, Rigon G, Carbone A, Sacchini D. Transvaginal estrogen therapy in urinary stress incontinence [in Italian]. Minerva Ginecol 1990;42:539-544.
31. Schmidbauer CP. Vaginal estriol administration in treatment of postmenopausal urinary incontinence [in German]. Urologe A 1992;31:384-389.
32. Schar G, Kochli OR, Fritz M, Heller U. Effect of vaginal estrogen therapy on urinary incontinence in postmenopause [in German]. Zentralbl Gynakol 1995;117:77-80.
33. Martan A, Masata J, Halaska M, Voigt R. Ultrasound imaging of the lower urinary tract in postmenopausal women with urinary stress or combined type of incontinence before and after intra vaginal administration of estriol [in Czechoslovakian]. Ceska Gynekol 1999;64: 6-9.
34. Lose G, Englev E. Estradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. BJOG 2000;107:1029-1034.
35. ISTAT (Istituto Nazionale di Statistica). 2001. Available at: http://demo.istat.it/popl/index.html.
36. Ingelman-Sundberg A, Ulmsten U. Urinary incontinence in women [in Swedish]. Lakartidningen 1976;73:4518-22.
37. Shumaker SA, Woman JF, Uebersax JS, McClish D, Fantl JA. Health-related quality-of-life measures for women with urinary incontinence-The incontinence impact questionnaire and the urogenital distress inventory. Qual Life Res 1994;3:291-306.
38. Mishell DR. Menopause: Physiology and Pharmacology. Chicago, IL: Yearbook Medical Publisher, 1987.
39. Wied GL, Bibbo M. Evaluation of endocrinologic condition by exfoliative cytology. In: Gold JJ, ed. Textbook of Gynaecologic Endocrinology. New York, NY: Harper and Row; 1975;117-155.
40. Schiff I, Wentworth B, Koos B, Ryan KJ, Tulchinsky D. Effect of estriol administration on the hypogonadal woman. Fertil Steril 1978;30:278-282.
41. Heimer GM. Estriol in the postmenopause. Acta Obstet Gynecol Scand Suppl 1987;139:1-23.
42. Romano JM, Kaye D. UTI in the elderly: common yet atypical. Geriatrics 1981;36:113-115.
43. Fedorkow DM. Estrogen as a therapy for stress urinry incontinence: a meta-analysis. JSOGC 1991;13:23-29
44. Fantl JA, Bump RC, Robinson D, McClish DK, Wyman JF, and The Continence Program for Women Research Group. Efficacy of estrogen supplementation in the treatment of urinary incontinence. Obstet Gynecol 1996;88:745-749.
45. Bhatia NN, Bergman A, Karram MM. Effects of estrogen on urethral function in women with urinary incontinence. Am J Obstet Gynecol 1989;160:176-181.
46. Hilton P, Stanton SL. The use of intravaginal estrogen cream in genuine stress incontinence. Br J Obstet Gynaecol 1983;90:940-944.
47. Benness C, Abbott D, Cardozo L, Cutner A, Whitehead M. Do progestogens exacerbate urinary incontinence in women on HRT? Neurourol Urodyn 1991;10:316-317.
48. Takahashi K, Okada M, Ozaki T, et al. Safety and efficacy of oestriol for symptoms of natural or surgically induced menopause. Hum Reprod 2000;15:1028-1036.